MYCBP 抗体 (AA 2-103)
Quick Overview for MYCBP 抗体 (AA 2-103) (ABIN7146032)
抗原
See all MYCBP 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 2-103
- 
                                            交叉反应
- 人
- 
                                            纯化方法
- >95%, Protein G purified
- 
                                            免疫原
- Recombinant Human c-Myc-binding protein (2-103AA)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Recommended dilution: IHC:1:20-1:200,
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - MYCBP (C-Myc Binding Protein (MYCBP))
- 
                                            别名
- MYCBP
- 
                                            背景
- 
                        Background: May control the transcriptional activity of MYC. Stimulates the activation of E box-dependent transcription by MYC. Aliases: AMY 1 antibody, AMY-1 antibody, AMY1 antibody, Associate of Myc 1 antibody, C myc binding protein antibody, C-Myc-binding protein antibody, Cmyc binding protein antibody, MYCBP antibody, MYCBP_HUMAN antibody 
- 
                                            UniProt
- Q99417
 抗原
- 
                    
 
                                     
                                     
                                    